Syntiron LLC, is dedicated to developing innovative vaccines for humans. Our patented microbial antigen discovery and purification technology targets proteins that acquire iron, a critical nutrient that is required for survival of the bacteria. These proteins are expressed on the cell surface and are similar among different strains, making them ideal vaccine antigens. Our proprietary platform enables rapid identification of these proteins, which can then be directly extracted from the host cell or produced recombinantly for preclinical vaccine development.
Looking for a particular Syntiron employee's phone or email?
The Syntiron annual revenue was $4 million in 2026.
Lisa Herron-Olson is the Managing Director of Syntiron.
8 people are employed at Syntiron.
Syntiron is based in Saint Paul, Minnesota.
The NAICS codes for Syntiron are [325414, 3254, 32541, 325, 32].
The SIC codes for Syntiron are [283, 28].